|
1
|
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study.
|
Lancet Neurol
|
2012
|
5.91
|
|
2
|
Idarucizumab for Dabigatran Reversal.
|
N Engl J Med
|
2015
|
5.91
|
|
3
|
Cryptogenic stroke and underlying atrial fibrillation.
|
N Engl J Med
|
2014
|
5.44
|
|
4
|
Using dabigatran in patients with stroke: a practical guide for clinicians.
|
Stroke
|
2011
|
2.97
|
|
5
|
Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage.
|
Stroke
|
2009
|
1.96
|
|
6
|
Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale.
|
Am Heart J
|
2010
|
1.76
|
|
7
|
Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage.
|
Neurocrit Care
|
2012
|
1.55
|
|
8
|
Amplification of acute focal ischemic deficit by narcotics.
|
Neurocrit Care
|
2008
|
1.44
|
|
9
|
Endovascular stroke therapy: a single-center retrospective review.
|
Neurosurg Focus
|
2011
|
1.44
|
|
10
|
Ictal sensory periodic lateralized epileptiform discharges.
|
Epilepsy Behav
|
2011
|
1.40
|
|
11
|
Surgical management of endocarditis: the society of thoracic surgeons clinical practice guideline.
|
Ann Thorac Surg
|
2011
|
1.36
|
|
12
|
Postpartum angiopathy and other cerebral vasoconstriction syndromes.
|
Neurocrit Care
|
2005
|
1.35
|
|
13
|
Endovascular stenting of extracranial carotid and vertebral artery dissections: a systematic review of the literature.
|
Neurosurgery
|
2011
|
1.29
|
|
14
|
Reduced platelet activity is associated with more intraventricular hemorrhage.
|
Neurosurgery
|
2009
|
1.05
|
|
15
|
Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF.
|
Arch Neurol
|
2005
|
1.03
|
|
16
|
Leukoaraiosis on magnetic resonance imaging correlates with worse outcomes after spontaneous intracerebral hemorrhage.
|
Stroke
|
2013
|
0.95
|
|
17
|
How patients die after intracerebral hemorrhage.
|
Neurocrit Care
|
2009
|
0.95
|
|
18
|
Rupture of cerebral myxomatous aneurysm months after resection of the primary cardiac tumor.
|
Neurocrit Care
|
2010
|
0.90
|
|
19
|
Platelet activity and outcome after intracerebral hemorrhage.
|
Ann Neurol
|
2009
|
0.90
|
|
20
|
Aspirin use or reduced platelet activity predicts craniotomy after intracerebral hemorrhage.
|
Neurocrit Care
|
2011
|
0.90
|
|
21
|
Oral clopidogrel load in aspirin-resistant capsular warning syndrome.
|
Neurocrit Care
|
2005
|
0.89
|
|
22
|
Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage.
|
Neurocrit Care
|
2010
|
0.87
|
|
23
|
Classification of cerebral infarction after subarachnoid hemorrhage impacts outcome.
|
Neurosurgery
|
2009
|
0.87
|
|
24
|
Symptomatic spontaneous intracranial carotid artery dissection treated with a self-expanding intracranial nitinol stent: a case report.
|
Surg Neurol
|
2008
|
0.85
|
|
25
|
Severe reversible cerebral vasoconstriction syndrome mimicking aneurysmal rupture and vasospasm.
|
Neurocrit Care
|
2007
|
0.85
|
|
26
|
Fever burden and functional recovery after subarachnoid hemorrhage.
|
Neurosurgery
|
2008
|
0.84
|
|
27
|
Quantitative cerebral MR perfusion imaging: preliminary results in stroke.
|
J Magn Reson Imaging
|
2010
|
0.84
|
|
28
|
Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin.
|
N Engl J Med
|
2003
|
0.82
|
|
29
|
Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections.
|
Cerebrovasc Dis
|
2014
|
0.82
|
|
30
|
Oral antiplatelet therapy.
|
JAMA
|
2005
|
0.82
|
|
31
|
Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients.
|
Neurocrit Care
|
2010
|
0.79
|
|
32
|
Duration of anticoagulation after cerebral venous sinus thrombosis.
|
Neurocrit Care
|
2012
|
0.78
|
|
33
|
Letter by Bernstein et al regarding article, "reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
|
Circulation
|
2012
|
0.78
|
|
34
|
Reversal of diffusion restriction after embolization of dural arteriovenous fistula: case report.
|
Neurosurgery
|
2010
|
0.77
|
|
35
|
Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage.
|
Neurocrit Care
|
2009
|
0.76
|
|
36
|
Hyperglycemia and insulin resistance in cardiac arrest patients treated with moderate hypothermia.
|
J Clin Endocrinol Metab
|
2014
|
0.75
|
|
37
|
Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH 2.
|
Neurology
|
2010
|
0.75
|
|
38
|
Use of dipyridamole in patients with recent stroke or TIA.
|
Am Fam Physician
|
2005
|
0.75
|
|
39
|
Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review.
|
Neurology
|
2011
|
0.75
|
|
40
|
Transient ischemic attack--proposed new definition.
|
N Engl J Med
|
2003
|
0.75
|
|
41
|
Recurrent artery-to-artery embolism during intravenous t-PA therapy for acute ischemic stroke.
|
Neurocrit Care
|
2005
|
0.75
|